| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| C Mehler-Wex, P Riederer, M Gerlac. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotoxicity research. vol 10. issue 3-4. 2007-03-20. PMID:17197367. |
dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. |
2007-03-20 |
2023-08-12 |
mouse |
| Rebecca Banerjee, Sen Sreetama, Karuppagounder S Saravanan, Goutam Chandra, Sailendra Nath De, Kochupurackal P Mohanakuma. Intrastriatal infusion of the Parkinsonian neurotoxin, MPP(+), induces damage of striatal cell nuclei in Sprague-Dawley rats. Journal of chemical neuroanatomy. vol 32. issue 2-4. 2007-03-19. PMID:16822645. |
the potent parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is known to destroy dopaminergic neurons of the basal ganglia. |
2007-03-19 |
2023-08-12 |
rat |
| I G Sil'ki. [A contribution of synaptic plasticity in the basal ganglia to processing of visual information]. Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova. vol 56. issue 6. 2007-03-01. PMID:17285769. |
excitation of dopaminergic cells by the visual stimulus via the superior colliculi requires parallel activation of a disinhibitory input to the superior colliculi via the thalamus and a "direct" pathway through the basal ganglia. |
2007-03-01 |
2023-08-12 |
Not clear |
| Héctor R Martínez, Leonel Cantú-Martínez, Humberto C González, Laura de León Flores, Héctor J Villarreal, Javier Onofre-Castill. Epilepsy, parkinsonism, and neuroleptic malignant syndrome in a child. Journal of child neurology. vol 21. issue 12. 2007-02-23. PMID:17156702. |
this case represents the unusual presentation of epilepsy, parkinsonism, and neuroleptic malignant syndrome, which might have a common pathophysiologic pathway (dopaminergic dysfunction) involving the basal ganglia and the hypothalamus. |
2007-02-23 |
2023-08-12 |
Not clear |
| Paola Piccini, David J Brook. New developments of brain imaging for Parkinson's disease and related disorders. Movement disorders : official journal of the Movement Disorder Society. vol 21. issue 12. 2007-02-20. PMID:16874751. |
parkinson's disease (pd) and related disorders are subcortical degenerations targeting the nigrostriatal dopaminergic system and basal ganglia. |
2007-02-20 |
2023-08-12 |
Not clear |
| Moran Weinberger, Neil Mahant, William D Hutchison, Andres M Lozano, Elena Moro, Mojgan Hodaie, Anthony E Lang, Jonathan O Dostrovsk. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease. Journal of neurophysiology. vol 96. issue 6. 2007-01-17. PMID:17005611. |
these findings suggest that the degree of neuronal beta oscillatory activity is related to the magnitude of the response of the basal ganglia to dopaminergic agents rather than directly to the motor symptoms of pd. |
2007-01-17 |
2023-08-12 |
Not clear |
| Shaji Theodore, Stephanie Stolberg, Wayne A Cass, William F Marago. Human immunodeficiency virus-1 protein tat and methamphetamine interactions. Annals of the New York Academy of Sciences. vol 1074. 2007-01-10. PMID:17105916. |
the abuse of methamphetamine (meth), which is great among this patient population, also affects the basal ganglia, causing degeneration of dopaminergic terminals. |
2007-01-10 |
2023-08-12 |
human |
| Matteo Bertelli, Stefano Cecchin, Cristina Lapucci, Gabriella Jacomelli, Hyder A Jinnah, Massimo Pandolfo, Vanna Michel. Study of the adenosinergic system in the brain of HPRT knockout mouse (Lesch-Nyhan disease). Clinica chimica acta; international journal of clinical chemistry. vol 373. issue 1-2. 2006-12-22. PMID:16793031. |
literature dates support the hypothesis that dopaminergic deficit and serotonergic excess in the circuit of basal ganglia are responsible for the aggressive behavior. |
2006-12-22 |
2023-08-12 |
mouse |
| E Bahn, S Siegert, T Pfander, M L Kramer, W J Schulz-Schaeffer, J W Hewett, X O Breakefield, J C Hedreen, K M Rostás. TorsinB expression in the developing human brain. Brain research. vol 1116. issue 1. 2006-12-12. PMID:16938275. |
expression of torsinb protein was detectable beginning at four to 8 weeks of age in the cerebellum (purkinje cells), substantia nigra (dopaminergic neurons), hippocampus and basal ganglia and was predominantly restricted to neuronal cells. |
2006-12-12 |
2023-08-12 |
human |
| Sacha B Nelson, Chris Hempel, Ken Sugin. Probing the transcriptome of neuronal cell types. Current opinion in neurobiology. vol 16. issue 5. 2006-12-12. PMID:16962313. |
microarray studies of purified cell types have enabled investigators to identify the transcriptional signatures of, for example, subtypes of pyramidal neurons and interneurons in the neocortex, modulatory dopaminergic and serotonergic neurons, and the striatal neurons that form the so-called 'direct' and 'indirect' pathways through the basal ganglia. |
2006-12-12 |
2023-08-12 |
Not clear |
| David J Scott, Mary M Heitzeg, Robert A Koeppe, Christian S Stohler, Jon-Kar Zubiet. Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 26. issue 42. 2006-11-14. PMID:17050717. |
in addition to its involvement in motor control and in encoding reward value, increasing evidence also implicates basal ganglia dopaminergic mechanisms in responses to stress and aversive stimuli. |
2006-11-14 |
2023-08-12 |
human |
| Ubaldo Bonuccelli, Paolo Del Dott. New pharmacologic horizons in the treatment of Parkinson disease. Neurology. vol 67. issue 7 Suppl 2. 2006-10-30. PMID:17030738. |
the nonphysiologic pulsatile stimulation of striatal dopamine receptors, produced by the currently available dopaminergic drugs, may trigger a dysregulation of many neurotransmitter systems within the basal ganglia, mainly localized on medium spiny striatal neurons. |
2006-10-30 |
2023-08-12 |
Not clear |
| Liborio Rampello, Alessandro Alvano, Giuseppe Battaglia, Valeria Bruno, Rocco Raffaele, Francesco Nicolett. Tic disorders: from pathophysiology to treatment. Journal of neurology. vol 253. issue 1. 2006-09-29. PMID:16331353. |
the pathophysiology of tics, at molecular and cellular level, is still unknown,whereas structural and functional neuroimaging studies have shown the involvement of the basal ganglia and related cortico-striato-thalamo-cortical circuits, and the dopaminergic neuronal system. |
2006-09-29 |
2023-08-12 |
Not clear |
| Maria Antonietta Macrì, Girolamo Garreffa, Federico Giove, Marta Moraschi, Giovanni Giulietti, Nicola Modugno, Claudio Colonnese, Bruno Maravigli. A cluster-based quantitative procedure in an fMRI study of Parkinson's disease. Magnetic resonance imaging. vol 24. issue 4. 2006-09-29. PMID:16677948. |
parkinson's disease is a neurological disorder associated with disfunction of dopaminergic pathways of the basal ganglia. |
2006-09-29 |
2023-08-12 |
human |
| Y Ben-Shaul, L Benmoyal-Segal, S Ben-Ari, H Bergman, H Sore. Adaptive acetylcholinesterase splicing patterns attenuate 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. The European journal of neuroscience. vol 23. issue 11. 2006-09-28. PMID:16819980. |
balanced dopaminergic cholinergic interactions are crucial for proper basal ganglia function. |
2006-09-28 |
2023-08-12 |
mouse |
| Melanie Hamann, Roger Raymond, Suneel Varughesi, José N Nobrega, Angelika Richte. Acetylcholine receptor binding and cholinergic interneuron density are unaltered in a genetic animal model of primary paroxysmal dystonia. Brain research. vol 1099. issue 1. 2006-09-19. PMID:16764832. |
in fact, numerous pharmacological, neurochemical, immunohistochemical and electrophysiological investigations in the dt(sz) hamsters, a unique rodent model of age-dependent primary paroxysmal dystonia, revealed alterations within the basal ganglia, particularly of the gabaergic and dopaminergic neurotransmitter systems. |
2006-09-19 |
2023-08-12 |
Not clear |
| Carol A Sege. The basal ganglia in human learning. The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry. vol 12. issue 4. 2006-09-19. PMID:16840704. |
current areas of research that are discussed include the differing roles of different basal ganglia regions, patterns of interaction between the cortex and basal ganglia, differences in positive and negative association learning, effects of dopaminergic medication on learning, whether basal ganglia-mediated learning is implicit or explicit, and how the basal ganglia learning systems interact with other learning systems, particularly within the medial temporal lobe. |
2006-09-19 |
2023-08-12 |
human |
| C Warren Olanow, José A Obeso, Fabrizio Stocch. Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease. Nature clinical practice. Neurology. vol 2. issue 7. 2006-09-15. PMID:16932589. |
dopaminergic neurons in the basal ganglia normally fire in a random but continuous manner, so that striatal dopamine concentrations are maintained at a relatively constant level. |
2006-09-15 |
2023-08-12 |
Not clear |
| Annette Møller Dall, Jens Zimme. Development of DARPP-32-positive parts of fetal pig ganglionic eminence and ventral mesencephalon in organotypic slice co-cultures. Experimental neurology. vol 200. issue 1. 2006-09-05. PMID:16529743. |
neurons from the fetal pig dopaminergic ventral mesencephalon (vm) and basal ganglia anlage (the ganglionic eminence) were co-cultured as organotypic slice cultures to study the development of the two interconnected brain areas. |
2006-09-05 |
2023-08-12 |
Not clear |
| C Warren Olanow, Jose A Obeso, Fabrizio Stocch. Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications. The Lancet. Neurology. vol 5. issue 8. 2006-09-05. PMID:16857573. |
rather, levodopa or other short-acting dopaminergic drugs induce molecular changes and altered neuronal firing patterns in basal ganglia neurons leading to motor complications. |
2006-09-05 |
2023-08-12 |
monkey |